Abstract:Background: Altered circulating levels and genetic variation of B-type natriuretic peptide (BNP), has been associated with lower bone mineral density (BMD) values and incidence of osteoporosis in peritoneal dialysis patients, renal transplant recipients, and postmenopausal women. The potential relationship of circulating BNP with osteoporosis in patients with type 2 diabetes mellitus (T2DM), however, has not yet been studied. Methods: Circulating BNP levels were measured in 314 patients with T2DM, and participants were divided into normal BMD group (n = 73), osteopenia group (n = 120), and osteoporosis group (n = 121). The association of circulating BNP with diabetic osteoporosis and other parameters was analyzed. Results: Circulating BNP was significantly higher in diabetic osteoporosis subjects than normal and osteopenia groups (P < 0.01 or P < 0.05). Circulating BNP levels correlated significantly and positively with neutrophil to lymphocyte ratio, systolic blood pressure, urinary albumin-to-creatinine ratio, and prevalence of hypertension, peripheral arterial disease, diabetic retinopathy, peripheral neuropathy, and nephropathy, and negatively with triglyceride, fasting blood glucose, lymphocyte count, hemoglobin, estimated glomerular filtration rate, bilirubin, osteoporosis self-assessment tool for Asians, BMD at different skeletal sites and corresponding T scores (P < 0.01 or P < 0.05). After multivariate adjustment, circulating BNP remained independently significantly associated with the presence of osteoporosis (odds ratio, 2.710; 95% confidence interval, 1.690-4.344; P < 0.01). BMD at the femoral neck and total hip and corresponding T scores were progressively decreased, whereas the prevalence of osteoporosis was progressively increased with increasing BNP quartiles (P for trend< 0.01). Moreover, receiver-operating characteristic analysis revealed that the optimal cutoff point of circulating BNP to indicate diabetic osteoporosis was 16.35 pg/ml. Conclusions: Circulating BNP level may be associated with the development of osteoporosis, and may be a potential biomarker for diabetic osteoporosis.

Levels of Brain Natriuretic Peptide Are Associated with Peripheral Arterial Disease in Subjects with Type-2 Diabetes Mellitus

Relationship between the extent of coronary artery lesions and plasma brain natriuretic peptide

Correlation Between B Type Natriuretic Peptide And Metabolic Risk Factors

Correlativity Between Plasma Brain Natriuretic Peptide Level and Cardial Metrical Indices in Hypertensive Patients

Plasma brain natriuretic peptide and atria natriuretic peptide as predictors for diastolic heart failure in patients with type 2 diabetes mellitus

Clinical significance and changes of plasma brain natriuretic peptide level in patients with chronic obstructive pul monary disease under different conditions

Levels of B-type natriuretic peptide in chronic heart failure patients with and without diabetes mellitus.

Changes in Brain Natriuretic Peptide Are Correlated with Changes in Global End-Diastolic Volume Index

Changes and Clinical Implications of Plasma ANP,BNP and CNP Levels in Type 2 Diabetic Patients with Vascular Complications

B-type Natriuretic Peptide and Risk of Type 2 Diabetes Mellitus

Association of circulating B-type natriuretic peptide with osteoporosis in a Chinese type 2 diabetic population

Serum brain-derived neurotrophic factor levels in patients with diabetic neuropathic pain

Role of B‐Type Natriuretic Peptide and N‐Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus

Study on Relationship Between Brain Natriuretic Peptide and Coronary Angiography

The Influence of Metabolic Syndrome and Diabetes Mellitus on the N-terminal Pro-B-type Natriuretic Peptide Level and Its Prognostic Performance in Patients with Coronary Artery Disease

Potential Effects of Peripheral Neuropathy on Brain Function in Patients with Type 2 Diabetes Mellitus

Emerging Role of Natriuretic Peptides in Diabetes Care: A Brief Review of Pertinent Recent Literature

Correlation Between Brain Natriuretic Peptide Levels and the Prognosis of Patients with Left Ventricular Diastolic Dysfunction.

AS-234 Plasma B-Type Natriuretic Peptide Levels Reflect the Presence and Severity of Stable Coronary Artery Disease in Diabetic Patients

N-terminal Pro-B-Type Natriuretic Peptide and Risk for Diabetes Mellitus and Metabolic Syndrome

Plasma Brain Natriuretic Peptide Levels in the Diagnosis of Heart Failure